MLTX Latest Headlines

Wedbush Sticks to Its Buy Rating for MoonLake Immunotherapeutics (MLTX)

at www.tipranks.com (Mon, 22-Dec 8:36 AM)

Shareholder Lawsuit Highlights Questions Over MoonLake’s Lead Drug Claims

Market Chameleon (Thu, 4-Dec 10:54 AM)

MoonLake Immunotherapeutics Secures $75 Million to Fuel Next Stage in Inflammatory Disease R&D

Market Chameleon (Wed, 5-Nov 7:44 AM)

Investor Lawsuit Follows Disappointing Phase 3 Trial Results at MoonLake Immunotherapeutics—Key Takeaways for Shareholders

Market Chameleon (Thu, 9-Oct 10:35 AM)

MoonLake Immunotherapeutics Faces Securities Investigation After Disappointing Phase 3 Results: What Investors Should Know

Market Chameleon (Mon, 6-Oct 10:44 AM)

Rosen Law Firm Launches Class Action Investigation Following MLTX’s 89.9% Decline After Trial Results

Market Chameleon (Fri, 3-Oct 10:40 AM)